12 2月 2019 by admin in UncategorizedComments NextCure Announces Formation of Scientific Advisory Board to Guide Development of its Portfolio of Immunomedicines
06 1月 2019 by admin in UncategorizedComments Syros Announces Strategic Priorities and Expected Milestones
03 1月 2019 by admin in UncategorizedComments Crescendo Biologics announces Humabody® evaluation in CAR-T by Takeda
05 12月 2018 by admin in UncategorizedComments Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 Clinical Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain
